UK To Go Ahead With Pre-Licensing Use Of COVID-19 Vaccines
Govt Addresses Concerns Over Safety, Liability and Workforce Expansion
Executive Summary
A consultation on plans for the early availability of coronavirus vaccines drew almost 192,000 responses, including a number of concerns to which the government has now responded.
You may also be interested in...
UK Vaccine Taskforce Leader Under Scrutiny After Investor Meeting
The UK has built one of the biggest and best ‘portfolios’ of COVID-19 vaccine candidates – but there are questions about its transparency and accountability.
UK Authorizes Use Of Unlicensed Flu Vaccine
A legislative provision under which future COVID-19 vaccines can be made available in the UK before they are approved is also being used to offer an unlicensed flu vaccine that officials say has undergone full safety, efficacy and quality tests.
BIA Applauds UK Plan For Pre-Approval Use Of Coronavirus Vaccine
The UK can already OK the use of unapproved products, but the government wants more certainty around the conditions that will be attached to any decision to make COVID-19 vaccines available before they have been licensed. Moves are also under way to reassure pharmaceutical companies about liability issues.